NCT06663917

Brief Summary

This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Oct 2024Oct 2027

Study Start

First participant enrolled

October 6, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2027

Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

3 years

First QC Date

October 28, 2024

Last Update Submit

August 29, 2025

Conditions

Outcome Measures

Primary Outcomes (15)

  • Sound Quality Questionnaire Score while using standard 188 Hz FAT

    A questionnaire will be given to the subjects to record their subjective thoughts regarding sound quality and satisfaction with both the experiment FAT and the standard FAT. Questionnaires will be administered double blind. Patients evaluate the 16-item questionnaire using a likert-scale (1-strongly disagree to 5-strongly agree). Lower scores indicate decreased sound quality and satisfaction, while higher scores indicate increased sound quality and satisfaction.

    Baseline

  • Sound Quality Questionnaire Score while using experimental 438 Hz FAT

    A questionnaire will be given to the subjects to record their subjective thoughts regarding sound quality and satisfaction with both the experiment FAT and the standard FAT. Questionnaires will be administered double blind. Patients evaluate the 16-item questionnaire using a likert-scale (1-strongly disagree to 5-strongly agree). Lower scores indicate decreased sound quality and satisfaction, while higher scores indicate increased sound quality and satisfaction.

    Behavioral Visit 2 (1 month post 438 Hz FAT adaptation)

  • Sound Quality Questionnaire Score while using standard 188 Hz FAT

    A questionnaire will be given to the subjects to record their subjective thoughts regarding sound quality and satisfaction with both the experiment FAT and the standard FAT. Questionnaires will be administered double blind. Patients evaluate the 16-item questionnaire using a likert-scale (1-strongly disagree to 5-strongly agree). Lower scores indicate decreased sound quality and satisfaction, while higher scores indicate increased sound quality and satisfaction.

    Behavioral Visit 3 (1 month post 188 Hz FAT re-adaptation)

  • The consonant-nucleus-consonant (CNC) word list score while using standard 188 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Baseline

  • CNC word list score while using standard 188 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Behavioral Visit 2 (1 month post 438 Hz FAT adaptation)

  • CNC word list score while using standard 188 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Behavioral Visit 3 (1 month post 188 Hz FAT re-adaptation)

  • CNC word list score while using experimental 438 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Baseline

  • CNC word list score while using experimental 438 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Behavioral Visit 2 (1 month post 438 Hz FAT adaptation)

  • CNC word list score while using experimental 438 Hz FAT

    CNC word lists are used to evaluate the speech perception abilities of people with hearing impairments and cochlear implant users. A CNC score above 50% postoperatively indicates that a patient can communicate without relying too much on lip reading, sign language, or written communication.

    Behavioral Visit 3 (1 month post 188 Hz FAT re-adaptation)

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using standard 188 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Baseline

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using standard 188 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Behavioral Visit 2 (1 month post 438 Hz FAT adaptation)

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using standard 188 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Behavioral Visit 3 (1 month post 188 Hz FAT re-adaptation)

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using experimental 438 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Baseline

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using experimental 438 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Behavioral Visit 2 (1 month post 438 Hz FAT adaptation)

  • Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score using experimental 438 Hz FAT

    The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

    Behavioral Visit 3 (1 month post 188 Hz FAT re-adaptation)

Study Arms (1)

Experienced Users

EXPERIMENTAL

All subjects will be fit with a modified cochlear implant program ("experimental FAT") that changes which frequencies are presented to the cochlear implant. Subjects will complete a 1 month adaptation to the experimental FAT (438 Hz) and then a one month re-adaptation to the standard FAT (188 Hz). Speech perception tests and questionnaires will be collected before and after each FAT adaptation.

Other: Experimental frequency allocation table (FAT) - 438 HzOther: Standard FAT - 188 Hz

Interventions

The modified cochlear implant program ("experimental FAT") changes which frequencies are presented to the cochlear implant. The experimental FAT frequency of 438 Hz will be loaded onto the subjects processor via the CI Select Mobile App. Subjects will use the experimental FAT for one month.

Experienced Users

All subjects will retain one program with the standard 188 Hz FAT. Subjects will use the standard FAT for one month.

Experienced Users

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments
  • Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear
  • Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear
  • Standard FAT use for all programs prior to study participation
  • No known anatomical abnormalities in either ear
  • English speaking
  • No known cognitive impairments
  • At least 25% of subjects should use the Cochlear EA32 electrode

You may not qualify if:

  • Under age 18
  • Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are validated in the English language. Additionally, study team members are not equipped to appropriately score speech testing materials validated in other languages.
  • Cognitively impaired
  • Non-consistent device usage
  • Greater than 70 dB hearing level pure tone average in the contralateral ear
  • Normal hearing or mild hearing loss in the contralateral ear
  • Non-standard FAT programs
  • Use of any frequency transposition programming in hearing aid.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

RECRUITING

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mario A. Svirsky, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2024

First Posted

October 29, 2024

Study Start

October 6, 2024

Primary Completion (Estimated)

October 6, 2027

Study Completion (Estimated)

October 6, 2027

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Data are available indefinitely in Databrary database (Link to be included when database is created). The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will be provided access upon reasonable request. Data are available indefinitely in Databrary database (Link to be included when database is created). To gain access, data requestors will need to sign a data access agreement.

Locations